Threshold of galactomannan antigenemia positivity for early diagnosis of invasive aspergillosis in neutropenic children

被引:22
|
作者
Dinand, Veronique [1 ]
Anjan, Madasu [1 ]
Oberoi, Jaswinder Kaur [2 ]
Khanna, Shilpi [2 ]
Yadav, Satya Prakash [1 ]
Wattal, Chand [2 ]
Sachdeva, Anupam [1 ]
机构
[1] Sir Ganga Ram Hosp, Dept Pediat, Pediat Hematol Oncol & Bone Marrow Transport Unit, New Delhi, India
[2] Sir Ganga Ram Hosp, Dept Clin Microbiol & Immunol, New Delhi, India
关键词
Aspergillosis; Child; Hematology/oncology; Infections in immunocompromised hosts; Neutropenia; Stem cell transplantation; LINKED-IMMUNOSORBENT-ASSAY; CELL TRANSPLANT RECIPIENTS; PROSPECTIVE CLINICAL-EVALUATION; POLYMERASE-CHAIN-REACTION; CANCER-PATIENTS; ENZYME-IMMUNOASSAY; IMMUNOCOMPROMISED PATIENTS; HEMATOLOGICAL PATIENTS; PEDIATRIC-PATIENTS; FUNGAL-INFECTIONS;
D O I
10.1016/j.jmii.2013.12.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose: Invasive aspergillosis (IA) is an important cause of morbidity and mortality in immunocompromised patients. Pediatric data on the accuracy and optimal cutoff of galactomannan antigen detection to diagnose IA is sparse and controversial. We evaluated the utility and optimal serum galactomannan assay (GA) cutoff in children. Methods: Children with febrile neutropenia due to malignancy, hematopoietic stem cell transplant, aplastic anemia, or congenital neutropenia, were prospectively included from 2007 to 2011. All new episodes of febrile neutropenia were recorded. In case of a previous diagnosis of IA, subsequent episodes were excluded. One to four GA were tested by enzyme immunoassay during each episode. Bronchoalveolar lavage and other relevant samples for mycological diagnosis, and computed tomography of chest/sinus were performed wherever appropriate. IA was classified as "proven", "probable", and "possible" as per the 2008 European Organisation for Research and Treatment of Cancer and Mycoses Study Group Guidelines. The optimal cutoff value was determined using receiver operating characteristic curves in episode-wise analysis. Results: There were 145 patients with 211 febrile episodes included: hematopoietic stem cell transplant (n = 15), oncological (n = 113), and hematological disorders (n = 17). Forty-five children (31.0%) developed IA (5 proven, 15 probable, and 25 possible). Cutoff value of single GA > 0.7 for proven/probable/possible IA offered the best combination of sensitivity (82.2%)/ specificity (82.5%), and 94.4% negative predictive value. Two consecutive positive GA >= 0.7 had a sensitivity/specificity of 75.0%/91.0%. Index GA >= 1.9 was associated with significantly higher mortality in children with IA and overall. Conclusion: Serum GA is sensitive to diagnose IA in pediatric patients with excellent negative predictive value at an optimal cutoff of >= 0.7. Considering two consecutive values >= 0.7 increases specificity to 91.0%. Copyright (C) 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:66 / 73
页数:8
相关论文
共 50 条
  • [21] Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis
    Hadrich, I.
    Makni, F.
    Cheikhrouhou, F.
    Neji, S.
    Amouri, I.
    Sellami, H.
    Trabelsi, H.
    Bellaaj, H.
    Elloumi, M.
    Ayadi, A.
    PATHOLOGIE BIOLOGIE, 2012, 60 (06): : 357 - 361
  • [22] Using the galactomannan assay in the diagnosis of invasive aspergillosis
    Wood-Morris, Robert
    Wortmann, Glenn
    AIDS READER, 2008, 18 (06): : 318 - 320
  • [23] Update on the contribution of galactomannan for the diagnosis of invasive aspergillosis
    Aquino, Valerio R.
    Goldani, Luciano Z.
    Pasqualotto, Alesssandro C.
    MYCOPATHOLOGIA, 2007, 163 (04) : 191 - 202
  • [24] Diagnosis of Invasive Aspergillosis: Use of the Galactomannan Assay
    Corinne N. Klein
    Christopher D. Pfeiffer
    Current Treatment Options in Infectious Diseases, 2015, 7 (3) : 163 - 175
  • [25] Serum galactomannan levels in the diagnosis of invasive aspergillosis
    Okuturlar, Yildiz
    Ozkalemkas, Fahir
    Ener, Beyza
    Serin, Sibel Ocak
    Kazak, Esra
    Ozcelik, Tulay
    Ozkocaman, Vildan
    Ozkan, Hasan Atilla
    Akalin, Halis
    Gunaldi, Meral
    Ali, Ridvan
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2015, 30 (06): : 899 - 905
  • [26] Galactomannan antigen detection in the diagnosis of invasive aspergillosis
    Verdaguer, Virginia
    Walsh, Thomas J.
    Hope, William
    Cortez, Karoll J.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2007, 7 (01) : 21 - 32
  • [27] Update on the contribution of galactomannan for the diagnosis of invasive aspergillosis
    Valério R. Aquino
    Luciano Z. Goldani
    Alesssandro C. Pasqualotto
    Mycopathologia, 2007, 163 : 191 - 202
  • [28] EVALUATION OF SERUM GALACTOMANNAN ASSAY FOR THE DIAGNOSIS OF INVASIVE ASPERGILLOSIS IN CHILDREN WITH HEMATOLOGICAL MALIGNANCIES
    Jha, Ajaya Kumar
    Bansal, Deepak
    Chakrabarti, Arunaloke
    Shivaprakash, M. R.
    Trehan, Amita
    Marwaha, Ram Kumar
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1112 - 1112
  • [29] EVALUATION OF SERUM GALACTOMANNAN ASSAY FOR THE DIAGNOSIS OF INVASIVE ASPERGILLOSIS IN CHILDREN WITH HEMATOLOGICAL MALIGNANCIES
    Jha, A.
    Bansal, D.
    Prakash, S.
    Chakraborty, A.
    HAEMATOLOGICA, 2015, 100 : 472 - 472
  • [30] Early diagnosis of invasive aspergillosis in infants and children
    Roilides, Emmanuel
    MEDICAL MYCOLOGY, 2006, 44 : S199 - S205